Anti Cancer New Program

ANTI ~ CANCER DRUGS Zenaida N. Maglaya, MD, FPSECP

Special Characteristics of Cancer Cells ,[object Object],[object Object],[object Object],[object Object]

Management of Cancer ,[object Object],[object Object],[object Object]

Mitosis M Synthetic S Pre-Synthetic G 1 Post –Synthetic G 2 DIFFEREN-TIATION G 0

Cell Cycle Non – Specific (CCNS) Agents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Cell Cycle Specific (CCS) Agents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

CANCER CHEMOTHERAPEUTIC AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object]

CANCER CHEMOTHERAPEUTIC AGENTS ,[object Object],[object Object],[object Object],[object Object]

CLASSIFICATION OF ANTI-CANCER DRUGS

POLYFUNCTIONAL ALKYLATING AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

POLYFUNCTIONAL ALKYLATING AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object]

RELATED DRUGS PROBABLY ACTING AS ALKYLATING AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object]

ANTIMETABOLITES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

PLANT ALKALOIDS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ANTIBIOTICS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

HORMONAL AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

HORMONAL AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

HORMONAL AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MISCELLANEOUS ANTI - CANCER DRUGS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MISCELLANEOUS ANTI - CANCER DRUGS ,[object Object],[object Object],[object Object],[object Object],[object Object]

MISCELLANEOUS ANTI - CANCER DRUGS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

RELATED DRUGS PROBABLY ACTING AS ALKYLATING AGENTS ,[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

METHOTREXATE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MERCAPTOPURINE (6 MP) & THIOGUANINE (6 TG) ,[object Object],[object Object],[object Object],[object Object],[object Object]

MERCAPTOPURINE (6 MP) & THIOGUANINE (6 TG) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

FLUOROURACIL ( 5FU) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

FLUOROURACIL ( 5FU) ,[object Object],[object Object],[object Object],[object Object],[object Object]

CYTARABINE (ARA-C) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

A. VINBLASTINE & VINCRISTINE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

B. ETOPOSIDE & TENIPOSIDE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

C. TOPOTECAN & IRINOTECAN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

D. PACLITAXEL & DOCETAXEL ,[object Object],[object Object],[object Object],[object Object],[object Object]

A. DOXORUBICIN & DAUNORUBICIN ,[object Object],[object Object],[object Object],[object Object]

B. BLEOMYCIN ,[object Object],[object Object],[object Object],[object Object],[object Object]

C. DACTINOMYCIN ,[object Object],[object Object],[object Object]

D. MITOMYCIN ,[object Object],[object Object],[object Object],[object Object]

HORMONAL ANTICANCER AGENTS ,[object Object],[object Object],[object Object],[object Object]

HORMONAL ANTICANCER AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object]

MISCELLANEOUS ANTICANCER AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object]

MISCELLANEOUS ANTICANCER AGENTS ,[object Object],[object Object],[object Object],[object Object]

GROWTH FACTOR RECEPTOR INHIBITORS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MISCELLANEOUS ANTICANCER AGENTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

STRATEGIES IN CANCER CHEMOTHERAPY ,[object Object],[object Object],[object Object],[object Object]

SAMPLES OF COMBINATION CHEMOTHERAPY ,[object Object],[object Object],[object Object],[object Object]

CANCER CHEMOTHERAPY ACRONYMS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ACRONYMS ,[object Object],[object Object],[object Object],[object Object],[object Object]

1. ACUTE LEUKEMIA ,[object Object],[object Object],[object Object]

2.CHRONIC LEUKEMIA ,[object Object],[object Object],[object Object],[object Object]

THE LYMPHOMAS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

CARCINOMA OF THE BREAST ,[object Object],[object Object],[object Object],[object Object],[object Object]

CARCINOMA ,[object Object],[object Object],[object Object],[object Object]

CARCINOMA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

CARCINOMA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

LUNG CARCINOMA ,[object Object],[object Object],[object Object],[object Object]

THANK YOU VERY MUCH !!! Cast your burden on the Lord. And He shall sustain you He shall never permit the Righteous to be moved. Psalm 55 : 22

Anti Cancer New Program

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

En vedette

En vedette (20)

Similaire à Anti Cancer New Program

Similaire à Anti Cancer New Program (20)

Plus de MD Specialclass

Plus de MD Specialclass (20)

Dernier

Dernier (20)

Anti Cancer New Program